1 Introduction to Research & Analysis Reports
1.1 Everolimus Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Everolimus Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Everolimus Overall Market Size
2.1 Global Everolimus Market Size: 2022 VS 2029
2.2 Global Everolimus Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Everolimus Sales: 2018-2029
3 Company Landscape
3.1 Top Everolimus Players in Global Market
3.2 Top Global Everolimus Companies Ranked by Revenue
3.3 Global Everolimus Revenue by Companies
3.4 Global Everolimus Sales by Companies
3.5 Global Everolimus Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Everolimus Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Everolimus Product Type
3.8 Tier 1, Tier 2 and Tier 3 Everolimus Players in Global Market
3.8.1 List of Global Tier 1 Everolimus Companies
3.8.2 List of Global Tier 2 and Tier 3 Everolimus Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Everolimus Market Size Markets, 2022 & 2029
4.1.2 2.5mg
4.1.3 5mg
4.1.4 7mg
4.1.5 10mg
4.2 By Type – Global Everolimus Revenue & Forecasts
4.2.1 By Type – Global Everolimus Revenue, 2018-2023
4.2.2 By Type – Global Everolimus Revenue, 2024-2029
4.2.3 By Type – Global Everolimus Revenue Market Share, 2018-2029
4.3 By Type – Global Everolimus Sales & Forecasts
4.3.1 By Type – Global Everolimus Sales, 2018-2023
4.3.2 By Type – Global Everolimus Sales, 2024-2029
4.3.3 By Type – Global Everolimus Sales Market Share, 2018-2029
4.4 By Type – Global Everolimus Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Everolimus Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Drugs Store
5.1.4 Other
5.2 By Application – Global Everolimus Revenue & Forecasts
5.2.1 By Application – Global Everolimus Revenue, 2018-2023
5.2.2 By Application – Global Everolimus Revenue, 2024-2029
5.2.3 By Application – Global Everolimus Revenue Market Share, 2018-2029
5.3 By Application – Global Everolimus Sales & Forecasts
5.3.1 By Application – Global Everolimus Sales, 2018-2023
5.3.2 By Application – Global Everolimus Sales, 2024-2029
5.3.3 By Application – Global Everolimus Sales Market Share, 2018-2029
5.4 By Application – Global Everolimus Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Everolimus Market Size, 2022 & 2029
6.2 By Region – Global Everolimus Revenue & Forecasts
6.2.1 By Region – Global Everolimus Revenue, 2018-2023
6.2.2 By Region – Global Everolimus Revenue, 2024-2029
6.2.3 By Region – Global Everolimus Revenue Market Share, 2018-2029
6.3 By Region – Global Everolimus Sales & Forecasts
6.3.1 By Region – Global Everolimus Sales, 2018-2023
6.3.2 By Region – Global Everolimus Sales, 2024-2029
6.3.3 By Region – Global Everolimus Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Everolimus Revenue, 2018-2029
6.4.2 By Country – North America Everolimus Sales, 2018-2029
6.4.3 US Everolimus Market Size, 2018-2029
6.4.4 Canada Everolimus Market Size, 2018-2029
6.4.5 Mexico Everolimus Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Everolimus Revenue, 2018-2029
6.5.2 By Country – Europe Everolimus Sales, 2018-2029
6.5.3 Germany Everolimus Market Size, 2018-2029
6.5.4 France Everolimus Market Size, 2018-2029
6.5.5 U.K. Everolimus Market Size, 2018-2029
6.5.6 Italy Everolimus Market Size, 2018-2029
6.5.7 Russia Everolimus Market Size, 2018-2029
6.5.8 Nordic Countries Everolimus Market Size, 2018-2029
6.5.9 Benelux Everolimus Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Everolimus Revenue, 2018-2029
6.6.2 By Region – Asia Everolimus Sales, 2018-2029
6.6.3 China Everolimus Market Size, 2018-2029
6.6.4 Japan Everolimus Market Size, 2018-2029
6.6.5 South Korea Everolimus Market Size, 2018-2029
6.6.6 Southeast Asia Everolimus Market Size, 2018-2029
6.6.7 India Everolimus Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Everolimus Revenue, 2018-2029
6.7.2 By Country – South America Everolimus Sales, 2018-2029
6.7.3 Brazil Everolimus Market Size, 2018-2029
6.7.4 Argentina Everolimus Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Everolimus Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Everolimus Sales, 2018-2029
6.8.3 Turkey Everolimus Market Size, 2018-2029
6.8.4 Israel Everolimus Market Size, 2018-2029
6.8.5 Saudi Arabia Everolimus Market Size, 2018-2029
6.8.6 UAE Everolimus Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Everolimus Major Product Offerings
7.1.4 Novartis Everolimus Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
8 Global Everolimus Production Capacity, Analysis
8.1 Global Everolimus Production Capacity, 2018-2029
8.2 Everolimus Production Capacity of Key Manufacturers in Global Market
8.3 Global Everolimus Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Everolimus Supply Chain Analysis
10.1 Everolimus Industry Value Chain
10.2 Everolimus Upstream Market
10.3 Everolimus Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Everolimus Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Everolimus in Global Market
Table 2. Top Everolimus Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Everolimus Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Everolimus Revenue Share by Companies, 2018-2023
Table 5. Global Everolimus Sales by Companies, (MT), 2018-2023
Table 6. Global Everolimus Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Everolimus Price (2018-2023) & (USD/Kg)
Table 8. Global Manufacturers Everolimus Product Type
Table 9. List of Global Tier 1 Everolimus Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Everolimus Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Everolimus Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Everolimus Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Everolimus Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Everolimus Sales (MT), 2018-2023
Table 15. By Type - Global Everolimus Sales (MT), 2024-2029
Table 16. By Application – Global Everolimus Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Everolimus Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Everolimus Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Everolimus Sales (MT), 2018-2023
Table 20. By Application - Global Everolimus Sales (MT), 2024-2029
Table 21. By Region – Global Everolimus Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Everolimus Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Everolimus Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Everolimus Sales (MT), 2018-2023
Table 25. By Region - Global Everolimus Sales (MT), 2024-2029
Table 26. By Country - North America Everolimus Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Everolimus Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Everolimus Sales, (MT), 2018-2023
Table 29. By Country - North America Everolimus Sales, (MT), 2024-2029
Table 30. By Country - Europe Everolimus Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Everolimus Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Everolimus Sales, (MT), 2018-2023
Table 33. By Country - Europe Everolimus Sales, (MT), 2024-2029
Table 34. By Region - Asia Everolimus Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Everolimus Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Everolimus Sales, (MT), 2018-2023
Table 37. By Region - Asia Everolimus Sales, (MT), 2024-2029
Table 38. By Country - South America Everolimus Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Everolimus Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Everolimus Sales, (MT), 2018-2023
Table 41. By Country - South America Everolimus Sales, (MT), 2024-2029
Table 42. By Country - Middle East & Africa Everolimus Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Everolimus Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Everolimus Sales, (MT), 2018-2023
Table 45. By Country - Middle East & Africa Everolimus Sales, (MT), 2024-2029
Table 46. Novartis Company Summary
Table 47. Novartis Everolimus Product Offerings
Table 48. Novartis Everolimus Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Everolimus Production Capacity (MT) of Key Manufacturers in Global Market, 2021-2023 (MT)
Table 51. Global Everolimus Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global Everolimus Production by Region, 2018-2023 (MT)
Table 53. Global Everolimus Production by Region, 2024-2029 (MT)
Table 54. Everolimus Market Opportunities & Trends in Global Market
Table 55. Everolimus Market Drivers in Global Market
Table 56. Everolimus Market Restraints in Global Market
Table 57. Everolimus Raw Materials
Table 58. Everolimus Raw Materials Suppliers in Global Market
Table 59. Typical Everolimus Downstream
Table 60. Everolimus Downstream Clients in Global Market
Table 61. Everolimus Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Everolimus Segment by Type in 2022
Figure 2. Everolimus Segment by Application in 2022
Figure 3. Global Everolimus Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Everolimus Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Everolimus Revenue, 2018-2029 (US$, Mn)
Figure 7. Everolimus Sales in Global Market: 2018-2029 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Everolimus Revenue in 2022
Figure 9. By Type - Global Everolimus Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Everolimus Revenue Market Share, 2018-2029
Figure 11. By Type - Global Everolimus Sales Market Share, 2018-2029
Figure 12. By Type - Global Everolimus Price (USD/Kg), 2018-2029
Figure 13. By Application - Global Everolimus Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Everolimus Revenue Market Share, 2018-2029
Figure 15. By Application - Global Everolimus Sales Market Share, 2018-2029
Figure 16. By Application - Global Everolimus Price (USD/Kg), 2018-2029
Figure 17. By Region - Global Everolimus Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Everolimus Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Everolimus Revenue Market Share, 2018-2029
Figure 20. By Region - Global Everolimus Sales Market Share, 2018-2029
Figure 21. By Country - North America Everolimus Revenue Market Share, 2018-2029
Figure 22. By Country - North America Everolimus Sales Market Share, 2018-2029
Figure 23. US Everolimus Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Everolimus Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Everolimus Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Everolimus Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Everolimus Sales Market Share, 2018-2029
Figure 28. Germany Everolimus Revenue, (US$, Mn), 2018-2029
Figure 29. France Everolimus Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Everolimus Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Everolimus Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Everolimus Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Everolimus Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Everolimus Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Everolimus Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Everolimus Sales Market Share, 2018-2029
Figure 37. China Everolimus Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Everolimus Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Everolimus Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Everolimus Revenue, (US$, Mn), 2018-2029
Figure 41. India Everolimus Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Everolimus Revenue Market Share, 2018-2029
Figure 43. By Country - South America Everolimus Sales Market Share, 2018-2029
Figure 44. Brazil Everolimus Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Everolimus Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Everolimus Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Everolimus Sales Market Share, 2018-2029
Figure 48. Turkey Everolimus Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Everolimus Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Everolimus Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Everolimus Revenue, (US$, Mn), 2018-2029
Figure 52. Global Everolimus Production Capacity (MT), 2018-2029
Figure 53. The Percentage of Production Everolimus by Region, 2022 VS 2029
Figure 54. Everolimus Industry Value Chain
Figure 55. Marketing Channels

※参考情報 エベロリムスについて詳しく説明いたします。エベロリムスは、分子標的薬の一種であり、特に経口投与が可能で、腫瘍やその他の疾患の治療に使用されます。この薬剤は、主に抗腫瘍作用を持ち、免疫抑制効果も備えています。ここでは、エベロリムスの定義、特徴、種類、用途、および関連技術について述べます。 エベロリムスは、拉致州の抗真菌薬であるラパマイシンから派生した化合物であり、mTOR（mechanistic target of rapamycin）経路を選択的に阻害することでその機能を発揮します。mTORは、細胞の成長、増殖、運動、サバイバルに関与する重要なシグナル伝達経路であり、さまざまな癌や代謝障害と関連しています。エベロリムスは、この経路を阻害することで、癌細胞の成長を抑制し、腫瘍の芽生えを抑えることが期待されています。 エベロリムスの特徴としては、その経口投与が可能であること、特定の癌の治療に対する効果が期待されること、免疫抑制作用があるため、臓器移植後の拒絶反応を防ぐために使われることが挙げられます。また、エベロリムスは、抗がん剤として単独で使用されることもありますが、他の抗癌剤との併用療法にも使用されることがあります。これにより、治療効果を高め、耐性の発生を抑えることが可能になります。 エベロリムスの用途は多岐にわたります。主に、ホルモン受容体陽性の乳癌、腎細胞癌、膵神経内分泌腫瘍（NET）、そして特定の種類の脳腫瘍など、さまざまな癌の治療に使用されます。また、エベロリムスは、臓器移植後の患者に対する免疫抑制療法においても重要な役割を果たしています。具体的には、腎移植後の拒絶反応を防止するために使用され、移植後の患者の生存率を向上させるために貢献しています。 エベロリムスを使用する際の関連技術には、患者の遺伝的背景や病状に応じた個別化医療が挙げられます。これにより、患者それぞれに最適な治療法を選択し、効果的な治療を行うことが可能になります。また、エベロリムスに対する耐性メカニズムの理解が進むことで、より効果的な治療法の開発が期待されます。さらに、mTOR経路をターゲットにした新しい治療薬の開発も進められており、今後の治療の選択肢が広がることが期待されています。 エベロリムスには副作用も存在します。最も一般的な副作用には、口内炎、感染症のリスクの増加、高血糖、肝機能障害などがあります。これらの副作用は患者ごとに異なるため、使用にあたっては慎重なモニタリングが必要です。また、エベロリムスと他の薬剤との相互作用にも注意が必要であり、特に代謝に関与する酵素の働きを変える可能性があるため、他の治療薬との併用には医療従事者による適切な判断が求められます。 エベロリムスは、がん治療や免疫抑制療法において、その特異なメカニズムと多様な適応により、重要な治療選択肢となっています。今後の研究によって、さらなる適応や使用方法の拡大が期待され、より多くの患者に対する治療の選択肢が提供されることが望まれます。また、エベロリムスの進化とともに、がん治療や臓器移植分野における新たな知見が生まれることが期待されています。 このように、エベロリムスはその独自の機能と多様な治療用途を持つ薬剤であり、今後も医学の発展に貢献し続けることが予想されます。具体的な臨床応用については、専門医の判断に基づく個別の治療計画が重要です。そして、エベロリムスを用いた新しい治療戦略やその効果を評価するための臨床試験も引き続き行われることでしょう。これにより、エベロリムスの持つ可能性がさらに明らかになり、より多くの患者に利益をもたらすことが期待されています。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer